Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk.

British journal of cancer - 1 Feb 1999

Siegelmann-Danieli N, Buetow K H

Abstract excerpt

The activity of the aromatase enzyme, which converts androgens into oestrogens and has a major role in regulating oestrogen levels in the breast, is thought to be a contributing factor in the development of breast cancer. We undertook this study to assess the role of constitutional genetic variat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Aromatase
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to DNA Primers

Share to Pedigree

Share to Risk Factors

Share to Sequence Analysis, DNA

Source

Open in PubMed Open full text

Identifiers

PMID: 10027313
DOI: 10.1038/sj.bjc.6690071
PMCID: PMC2362434

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-10027313-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk.PMID 10027313Read ↗

A rare CYP19 (aromatase) variant may increase the risk of breast cancer.Semantic proximity Read ↗

Human aromatase: gene resequencing and functional genomics.Semantic proximity Read ↗

Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.Semantic proximity Read ↗

Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors.Semantic proximity Read ↗

A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk.Semantic proximity Read ↗

Polymorphic variation in CYP19 and the risk of breast cancer.Semantic proximity Read ↗

Effect of CYP19 rs6493497 and rs7176005 haplotype status on in vivo aromatase transcription, plasma and tissue estrogen levels in postmenopausal women.Semantic proximity Read ↗

Genetic variants of CYP19 (aromatase) and breast cancer risk.Semantic proximity Read ↗

<i>CYP19</i> (aromatase) haplotypes and endometrial cancer riskSemantic proximity Read ↗

Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.Semantic proximity Read ↗

Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer.Semantic proximity Read ↗

Identification of CYP19A1 single-nucleotide polymorphisms and their haplotype distributions in a Korean population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.